Carsten Thiel is a biotechnology executive who has worked around the world. He was the chief executive officer of Abeona Therapeutics, Inc. which creates cell and gene therapies. The focus is on helping people who have life-threatening rare genetic diseases.
He has been in the biotechnology business since 1994 when he joined Hoffman-La Roche. Carsten Thiel is originally from Germany and went to college in the United Kingdom. His career has taken him to Slovenia, Switzerland, Austria, and the United States. He currently lives in the New York City area.
Over the past 25 years, he has brought several high-profile medical products to market. Among these are Prolia, Neulasta, and Vectibix. He has been highly involved in marketing products that have improved the lives of people around the world. He says that he approaches marketing with medical ethics being the first and foremost concern. He wants to help doctors develop more cohesive patient care plans and do his part to support the provider-patient relationship.
Carsten Thiel’s early career success led to him being put in charge of the marketing campaign for a new weight loss product, Xenical. He already had experience marketing vitamins and supplements so he was well-suited to the task of getting people to know about Xenical. He started out by crafting credible and realistic communications that were sent out to health care providers. As Xenical became more established Carsten Thiel advertised to the general mass. This lead to a steady incline of people using Xenical to drop excess pounds.
He says both of his parents were medical doctors. He thought he would pursue the same path but instead chose to be in the medical field in a different way that would take advantage of his interests and abilities. He developed a keen interest in how DNA works and decided that his career path would be exploring this subject.
Carsten Thiel’s: Facebook Page.